Non-Invasive Prenatal Testing (NIPT) Market Size is Set to Grow at a Remarkable Pace in the Coming Years
Portland, OR -- (SBWIRE) -- 08/29/2017 -- Non-invasive prenatal testing is also known as non-invasive parenteral screening, which is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.
Access full summary at: https://www.alliedmarketresearch.com/non-invasive-prenatal-testing-nipt-market
Growth in reimbursements for the NIPT sector, increased shift from invasive methods to non-invasive methods, and growth of maternal age (associated with growth in the risk of chromosomal abnormalities in babies) drive the market. In addition, launch and development of advanced and new technologies and non-invasive parenteral testing products also fuels the market growth. However, lack of skilled professionals as well as strict regulatory guidelines and ethical hurdles slow down the process of approvals and marketing, thus restricting the market growth. Untapped emergence of new market in Asia-Pacific make way for growth opportunities for his market.
The key players of non-invasive parenteral testing market are Ge Healthcare (General Electric Company), Koninklijke Philips N.V., Illumina, Inc., Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd., Pacific Biosciences of California, Inc., Perkinelmer, Inc., Qiagen N.V., Agilent Technologies, Inc., and Beijing Genomics Institute.
Non-invasive Prenatal Testing (Nipt) Market Key Segmentation:
o Assay Kits & Reagents
o Ultrasound Devices
o Next-Generation Sequencing Systems
o Polymerase Chain Reaction Instruments
o Other Instruments
- Ultrasound Detection
- Biochemical Screening Tests
- Cell-Free DNA in Maternal Plasma Tests
- Fetal Cells in Maternal Blood Tests
- Microdeletion Syndrome
- Other Applications
By End User
- Diagnostic Laboratories
- North America
o Rest of Europe
o Rest of Asia-Pacific
o Saudi Arabia
o South Africa
o South Korea
o Rest of LAMEA
Request TOC and Sample Report: https://www.alliedmarketresearch.com/request-toc-and-sample/2706
About Allied Market Research
Allied Market Research is a Market Research Company which offers Syndicate & Custom Market Research Reports with Consulting Services.
5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
Toll Free: +1-800-792-5285